Application 214831

Type
ANDA
Sponsor
ANNORA PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002BRIVARACETAMBRIVARACETAMTABLET; ORAL25mgNoNo
003BRIVARACETAMBRIVARACETAMTABLET; ORAL50mgNoNo
004BRIVARACETAMBRIVARACETAMTABLET; ORAL75mgNoNo
005BRIVARACETAMBRIVARACETAMTABLET; ORAL100mgNoNo

Source provenance: Browse the complete Orange Book source catalog.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
brivaracetamBRIVARACETAMZydus Pharmaceuticals USA Inc.d54ca946-2ddf-4a67-87c9-20a814bfd2dc2026-01-27Warnings, Adverse reactionsName fallback
brand name: brivaracetam
generic name: BRIVARACETAM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.